AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Kraaijenhagen, RA Buller, HR
Citation: Ra. Kraaijenhagen et Hr. Buller, Travel and risk of venous thrombosis - Reply, LANCET, 357(9255), 2001, pp. 554-554

Authors: Boon, D Kraaijenhagen, RA van Montfrans, GA
Citation: D. Boon et al., Factitious pheochromocytoma-like hypertensive bouts caused by the valsalvamaneuver, ANN INT MED, 135(4), 2001, pp. 304-305

Authors: Kraaijenhagen, RA Anker, PSI Koopman, MMW Reitsma, PH Prins, MH van den Ende, A Buller, HR
Citation: Ra. Kraaijenhagen et al., High plasma concentration of factor ville is a major risk factor for venous thromboembolism, THROMB HAEM, 83(1), 2000, pp. 5-9

Authors: van der Velde, EF Kraaijenhagen, RA van Weert, HCPM Turkstra, F Buller, HR
Citation: Ef. Van Der Velde et al., Survey of the management of deep vein thrombosis in general practice in the Netherlands, NETH J MED, 57(4), 2000, pp. 135-141

Authors: Kraaijenhagen, RA Haverkamp, D Koopman, MNW Prandoni, P Piovella, F Buller, HR
Citation: Ra. Kraaijenhagen et al., Travel and risk of venous thrombosis, LANCET, 356(9240), 2000, pp. 1492-1493

Authors: van der Heijden, JF Kraaijenhagen, RA Buller, HR
Citation: Jf. Van Der Heijden et al., The risk of recurrent deep venous thrombosis, N ENG J MED, 342(3), 2000, pp. 214-215

Authors: Buller, HR Cariou, R Gallus, A Gent, M Ginsberg, J Prins, MH Lensing, A Levi, M Nurmohammed, N Hirsh, J Roberts, R ten Cate, JW Decousus, H Mismetti, P Buchmuller, A Charlet, V Viallon, A van der Meer, J Meinardi, JR Meijer, K Piovella, F Barone, M Beltrametti, C Serafini, S Kraaijenhagen, RA Koopman, MMW Jagt, HHT Muller, MBR Kooy, MV Nauta, S Gallus, AS Coghlan, D Rich, C Prandoni, P Scudeller, A Scarano, L Girolami, A Baker, R Tan, E Cooney, J Eikelboom, J Ninet, J Dolmazon, C Madoux, MHG Coppere, B Nenci, GG Agnelli, G Falcinelli, F Morini, M d'Angelo, A Crippa, L d'Angelo, SV Chong, B Chestreman, C Malvin, J Eisbacher, M MacGillavry, MR Brandjes, DPM Beaumont, JFM Olmos, RAV Turpie, AGG Johnson, J Nowacki, B Anderson, D Pleasance, S Mitchell, M Ockelford, P Bennett, A Jones, R Porteous, F Weitz, J Kearon, C Simonneau, G Parent, F Douketis, J Schnurr, T Hainaut, P Petit, B Jaumotte, C Huisman, MV van Poelgeest, MIE Meinders, AE van Oostayen, JA Beer, J Lugli, A Pederiva, S Ginsberg, J Brill-Edwards, P Stevens, P Bassand, JP Seronde, MF Kassis, J Fortin, M Faivre, R Petiteau, PY Verhaeghe, R Wells, P Lewandowski, B Touchie, D Banga, JD Hartmann, IJC Zeguers, VJM Desjardins, L Villeneuve, J Cote, J Bounameaux, H Cirafici, P Demers, C van der Heul, C Kruip, M
Citation: Hr. Buller et al., Treatment of proximal deep vein thrombosis with a novel synthetic compound(SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation, CIRCULATION, 102(22), 2000, pp. 2726-2731

Authors: Hutten, BA Lensing, AWA Kraaijenhagen, RA Prins, MH
Citation: Ba. Hutten et al., Safety of treatment with oral anticoagulants in the elderly - A systematicreview, DRUG AGING, 14(4), 1999, pp. 303-312

Authors: Kraaijenhagen, RA Lensing, AWA Wallis, JW van Beek, EJR ten Cate, JW Buller, HR
Citation: Ra. Kraaijenhagen et al., Diagnostic management of venous thromboembolism, BAIL CLIN H, 11(3), 1998, pp. 541-586
Risultati: 1-9 |